Here we report that mice with T cell-specific deletion of the miR-17~92 family of microRNAs (miRNAs) had substantially compromised T FH differentiation, germinal-center formation and antibody responses and failed to control chronic viral infection. Conversely, mice with T cell-specific expression of a transgene encoding miR-17~92 spontaneously accumulated T FH cells and developed a fatal immunopathology. Mechanistically, the miR-17~92 family controlled the migration of CD4 + T cells into B cell follicles by regulating signaling intensity from the inducible costimulator ICOS and kinase PI(3)K by suppressing expression of the phosphatase PHLPP2. Our findings demonstrate an essential role for the miR-17~92 family in T FH differentiation and establish PHLPP2 as an important mediator of their function in this process.
MicroRNAs (miRNAs) are endogenously encoded small RNAs ~22 nucleotides in length with important roles in a large diversity of biological processes [1] [2] [3] . Genetic studies have shown that miRNAs are important regulators in the immune system 4, 5 . However, the functions of individual miRNAs during lymphocyte development and effector cell differentiation remain largely unknown. The miRNA clusters miR-17~92, miR-106a~363 and miR-106b~25 are members of the highly conserved miR-17~92 family 6 . Together, these three clusters encode thirteen distinct miRNAs, which belong to four miRNA subfamilies (miR-17, miR-18, miR-19 and miR-92). Members of each subfamily share a common 'seed region' (nucleotides 2-7 of mature miRNA) and are thought to have similar functions. Germline deletion of miR-17~92 leads to perinatal death of mutant mice. Whereas ablation of miR-106a~363 or miR-106b~25 has no obvious phenotypic consequence, compound mutant embryos lacking both miR-17~92 and miR-106b~25 die before embryonic day 15, with defective development of the lungs, heart, central nervous system and B lymphocytes 7 . Such genetic studies have identified essential and overlapping functions for members of the miR-17~92 family in many developmental processes.
T cell help is essential for humoral immune responses. A distinct CD4 + effector T cell subset, the follicular helper T cells (T FH cells), provides such help to B cells 8 . However, the molecular mechanisms that underlie T FH differentiation are still largely unknown. Bcl-6 has been identified as a critical transcription factor that regulates T FH differentiation [9] [10] [11] . A study has reported that Bcl-6 represses the expression of miR-17~92, which targets the expression of CXCR5, a chemokine receptor essential for migration of CD4 + T cells to B cell follicles, and has suggested that miR-17~92 functions as a negative regulator of T FH differentiation (the 'repression of the repressors' model) 11 . Here we explore the role of the miR-17~92 family of miRNAs in T FH differentiation and germinal-center (GC) reactions through the use of mice with loss-and gain-of function mutations in genes encoding those miRNAs. We find that those miRNAs functioned as critical positive regulators of T FH differentiation by controlling the migration CD4 + T cells into B cell follicles, and we identify the phosphatase PHLPP2 as an important mediator of their function in this process.
RESULTS

The miR-17~92 family regulates T FH differentiation
We first examined expression of the miR-17~92 family of miRNAs during T FH differentiation. Consistent with a published report 11 , expression of these miRNAs was lower in T FH cells than in naive CD4 + T cells at day 7 after immunization of wild-type mice with ovalbumin (OVA) in the adjuvant alum plus lipopolysaccharide (LPS) (Fig. 1a) . In naive CD4 + T cells activated in vitro with antibody to CD3 (anti-CD3) and anti-CD28, the expression of these miRNAs increased during the first 2 d, peaked around day 2 and decreased afterward (Fig. 1b) . These results suggested that expression of the miR-17~92 family was induced early in T cell activation and then was repressed after completion of the T FH -differentiation program.
To investigate the role of miR-17~92 family in T FH differentiation, we generated mice with loxP-flanked alleles encoding miR-17~92 (Mirc1 fl/fl ) deleted by Cre recombinase expressed from the T cell-specific Cd4 promoter (CD4-Cre + Mirc1 fl/fl ; called A r t i c l e s 'CD4-Cre + miR-17~92 fl/fl ' here) that also had homozygous deficiency in miR-106a~363 (Mirc2 −/− ; called 'miR-106a~363 −/− ' here) and miR-106b~25 (Mirc3 −/− ; called 'miR-106b~25 −/− ' here; collectively called 'CD4tKO' mice here) and confirmed loss of expression of miR-17~92, miR-106a~363 and miR-106b~25 in T cells from CD4tKO mice 7, 12 (Fig. 1c) . CD4tKO mice had grossly normal lymphocyte development and follicular structures in lymphoid organs (data not shown). We assessed T FH differentiation by immunizing mice with a T cell-dependent antigen, the haptenated protein 4-hydroxy-3-nitrophenyl linked to OVA (NP-OVA), precipitated in alum together with LPS or with NP linked to chicken γ-globulin (NP-CGG) in alum. CD4tKO mice had considerably impaired differentiation of T FH cells ( Fig. 1d ) and GC B cells ( Fig. 1e ) and produced less NP-specific immunoglobulin M (IgM; 30-50% that of wild-type mice on day 7; data not shown) and IgG1 (~7% that of wild-type mice on day 7 and 30~50% that of wild-type mice on days 14 and 21; Fig. 1f , left). CD4tKO mice also had a defective secondary antibody response (50% that of wild-type mice at all time points) after reimmunization ( Fig. 1f, right) , which suggested that the miR-17~92 family regulated not only the initial formation and function of T FH cells but also the establishment of long-lived protective CD4 + T cell-dependent B cell responses. Immunohistochemistry showed that the spleens of immunized CD4tKO mice had considerably fewer and smaller GCs than did their wild-type counterparts ( Fig. 1g and data not shown). In contrast, miR-17~92 fl/fl miR-106a~363 −/− miR-106b~25 −/− mice (with germline deletion of both the miR-106a~363 and miR-106b~25 clusters; collectively called 'dKO' mice here) had slightly less T FH differentiation, GC B cell formation and antibody production than did their wild-type counterparts ( Supplementary  Fig. 1a-c) . Similarly, CD4-Cre + miR-17~92 fl/fl mice also had slightly Figure 1 The miR-17~92 family regulates T FH differentiation during immunization with protein antigen. (a-c) RNA blot analysis of the miR-17~92 family in sorted naive CD4 + T cells (Naive) and CXCR5 hi PD-1 hi T FH cells (T FH ; a), in naive (0) and activated (1-5) wild-type CD4 + T cells (b) and in naive wild-type (WT) and CD4tKO CD4 + T cells (c; n = 3 mice per genotype); results are presented as the ratio of miRNA to the small nuclear RNA U6, relative to that in naive wild-type CD4 + T cells. (d,e) Flow cytometry of cells obtained on days 0, 7 and 14 after intraperitoneal immunization of mice with NP-OVA in alum plus LPS (left); numbers adjacent to outlined areas indicate percent CXCR5 hi PD-1 hi cells (d) or GL7 + Fas + cells (e). Right, frequency of CXCR5 hi PD-1 hi T FH cells among CD4 + T cells (d) or GL7 + Fas + GC B cells among B220 + cells (e) for all mice (n = 6 per group). (f) Enzymelinked immunosorbent assay (ELISA) of NP-specific IgG1 in serum from wild-type and CD4tKO mice (n = 8 per group) obtained 0-126 d (horizontal axis) after mice were given primary intraperitoneal immunization with 10 µg NP-CGG (nitrophenyl linked to chicken γ-globulin) in alum, followed by secondary intraperitoneal immunization with 5 µg NP-CGG on day 111 after that primary immunization (protocol, top). Each symbol represents an individual mouse; small horizontal lines indicate the mean. (g) Immunohistochemistry of GCs in the spleens of wild-type and CD4tKO mice 7 d after intraperitoneal immunization with NP-OVA in alum plus LPS. Scale bars, 50 µm. (h) T FH differentiation in the spleen of lethally irradiated Ly5a + B6 mice reconstituted with Ly5a + Ly5b + B6 bone marrow plus Ly5b + CD4tKO bone marrow (1:1), then immunized intraperitoneally with NP-OVA in alum plus LPS at 8 weeks after reconstitution and analyzed 7 or 14 d after immunization (left); numbers adjacent to outlined areas as in d. Right, frequency of CXCR5 hi PD-1 hi T FH cells among CD4 + T cells for all mice. *P < 0.05 and **P < 0.01 (Student's unpaired t-test). Data are representative of two independent experiments (a,c-g,h; mean and s.e.m. in d,e,h) or three independent experiments (b). npg less differentiation of T FH cells and GC B cells after protein antigen immunization than did their wild-type counterparts, although this was more pronounced than that of dKO mice ( Supplementary  Fig. 2) . These results showed essential and overlapping functions for the miR-17~92 family during T FH differentiation.
To determine whether the compromised T FH differentiation in CD4tKO mice reflected a cell-intrinsic miRNA function, we generated wild-type-CD4tKO mixed-bone marrow chimeras by reconstituting Ly5a + C57BL/6 (B6) mice with a mixture of wild-type (Ly5a + Ly5b + ) and CD4tKO (Ly5b + ) bone marrow, then immunized the recipients with NP-OVA in alum plus LPS. Although wild-type CD4 + T cells differentiated into T FH cells, CD4tKO CD4 + T cells contributed very little to the T FH cell pool in chimeric mice ( Fig. 1h) . In contrast, dKO CD4 + T cells and B cells underwent relatively normal differentiation into T FH cells and GC B cells in wild-type (Ly5a + ) dKO (Ly5b + ) chimeras generated in Ly5a + Ly5b + B6 mice ( Supplementary Fig. 1d ). These results demonstrated that the miR-17~92 family functioned as a CD4 + T cell-intrinsic positive regulator of T FH differentiation.
CD4tKO mice do not control chronic viral infection
Studies suggest that T FH cells have important roles in controlling chronic viral infection 13, 14 . Infection of mice with a high dose of lymphocytic choriomeningitis virus (LCMV) clone 13 (2 × 10 6 plaque-forming units, administered intravenously) results in chronic infection, with virus persisting for 3-4 months in multiple tissues 15 . Infection of CD4tKO mice with LCMV clone 13 resulted in less T FH differentiation ( Fig. 2a,b ) and formation of GC B cells ( Fig. 2c ) than that of their wild-type counterparts, as well as less less production of LCMV-specific IgG (16-30% that of their wild-type counterparts; Fig. 2d and Supplementary Fig. 3a ). CD4tKO CD4 + T cells were considerably impaired in their ability to produce interleukin 21 (IL-21) ( Fig. 2e) , a cytokine critical for T FH differentiation, the formation of GC B cells and functional CD8 + T cell responses during chronic viral infection [16] [17] [18] [19] [20] [21] [22] . We also investigated CD8 + T cell responses during infection with LCMV clone 13. We found no substantial difference between CD4tKO and wild-type mice in the frequency or total number of CD8 + T cells specific for LCMV glycoprotein amino acids 33-41 or 276-286 ( Supplementary Fig. 3b,c) . However, virus-specific CD4tKO CD8 + T cells had higher expression of the negative immunoregulatory molecule PD-1 than did their wild-type counterparts ( Supplementary Fig. 3d ), which suggested a more exhausted state 23 , and had a smaller percentage of cells that produced both interferon-γ (IFN-γ) and tumor-necrosis factor ( Supplementary Fig. 3e,f) . Finally, we investigated whether the impaired development of T FH cells and GC B cells, compromised production of antibodies and cytokines and enhanced CD8 + T cell exhaustion in CD4tKO mice led to a diminished ability to control infection with LCMV clone 13. CD4tKO mice infected with LCMV clone 13 had higher titers of virus in the serum at days 20, 30 and 50 after infection than did their wild-type or dKO counterparts ( Fig. 2f and data not shown). At day 80 after infection, when all wild-type and dKO mice had completely cleared the virus from the serum, CD4tKO mice maintained over four 'logs' (plaqueforming units, measured as a logarithm) of virus ( Fig. 2f and data not shown). Moreover, CD4tKO mice had substantial viral loads in serum and multiple tissues at day 140 after infection, a time when virus was eliminated from all tissues except kidney in wild-type and dKO mice ( Fig. 2g and data not shown). Together our results demonstrated that CD4tKO mice had defective T FH differentiation during infection with LCMV clone 13 and failed to control the virus.
Accumulation of T FH cells in miR-17~92-transgenic mice
Next we determined whether miR-17~92 overexpression was sufficient to promote the generation of functional T FH cells. We developed mice with transgenic expression of miR-17~92 specifically in T cells ('CD4-Cre + miR-17~92 tg/tg ' mice; called '17~92 tg/tg ' mice here) and found four-to sixfold higher expression of miR-17~92 in 17~92 tg/tg CD4 + T cells than wild-type CD4 + T cells 24 (Fig. 3a) . Young 17~92 tg/tg mice had more effector-memory CD44 + CD4 + T cells in the spleen than did wild-type mice ( Supplementary Fig. 4a,b) . Young 17~92 tg/tg mice showed spontaneous T FH differentiation and formation of GC B cells, whereas the proportion of other helper T cell subsets among CD44 + CD4 + T cells was not affected ( Fig. 3b and Supplementary Fig. 4c,d) . 
npg
A r t i c l e s Those spontaneously generated T FH -like cells expressed Bcl-6, the signature transcription factor of T FH cells (Fig. 3b) . T FH cell population expansion has been observed in a subset of patients with lupus and in sanroque mice, a mutant mouse strain that spontaneously develops systemic autoimmunity, and has been shown to serve a causative role in the latter [25] [26] [27] . We monitored disease development in wild-type and 17~92 tg/tg mice for more than 20 months. All 17~92 tg/tg mice died prematurely, with an average lifespan of 40 weeks (Fig. 3c) . Examination of sick 17~92 tg/tg mice showed that they developed splenomegaly and lymphadenopathy ( Supplementary Fig. 4e ), accumulated T FH cells and GC B cells in lymphoid organs ( Fig. 3d) , produced autoantibodies to double-stranded DNA ( Fig. 3e ) and had infiltration of lymphocytes in nonlymphoid organs (Supplementary Fig. 4f) . Therefore, T cellspecific overexpression of miR-17~92 caused spontaneous T FH differentiation and fatal immunopathology.
To demonstrate that the enhanced T FH differentiation in 17~92 tg/tg mice was intrinsic to CD4 + T cells, we generated wild-type-17~92 tg/tg mixed-bone marrow chimeras by reconstituting mice deficient in recombination-activating gene 1 with a mixture of wild-type and 17~92 tg/tg bone marrow. At 3 months after reconstitution, a significantly greater proportion of 17~92 tg/tg CD4 + T cells than wild-type CD4 + T cells acquired a T FH phenotype; in fact, most wild-type CD4 + T cells remained undifferentiated (Fig. 3f) . In addition, retroviral overexpression of miR-17~92 in naive wild-type CD4 + T cells led to twofold more T FH differentiation in vitro than that in cells infected with control retrovirus, whereas differentiation into the T helper type 1 (T H 1) subset was not affected (Fig. 3g) . Retroviral overexpression of miR-17~92 promoted T FH differentiation without increasing Bcl-6 protein in the differentiated CXCR5 + PD-1 hi T FH cells ( Supplementary  Fig. 5 ). These data suggested that Bcl-6 protein was not directly controlled by the miR-17~92 family. Together these results showed that overexpression of miR-17~92 was sufficient to drive T FH differentiation and that this effect was intrinsic to CD4 + T cells.
CD4tKO CD4 + T cells do not migrate into B cell follicles
We introduced the transgene encoding the OVA-specific OT-II T cell antigen receptor into CD4tKO mice to study the effect of the miR-17~92 family on antigen-specific CD4 + T cells during T FH differentiation 28 . We labeled naive Ly5b + wild-type or CD4tKO OT-II CD4 + T cells with the cytosolic dye CFSE and adoptively transferred them npg into Ly5a + C57BL/6 (B6) recipients, immunized the recipients with OVA in alum and analyzed the transferred OT-II CD4 + T cells at various time points. In agreement with our results reported above (Fig. 1d) , CD4tKO OT-II CD4 + T cells failed to differentiate effectively into Bcl-6 + CXCR5 hi T FH cells by day 6.5 (Fig. 4a) . We examined cell proliferation and upregulation of the expression of activation markers and of other molecules functionally important for T FH differentiation on days 2.5, 3.5 and 6.5 after immunization. The proliferation of CD4tKO OT-II CD4 + T cells was similar to that of their wild-type counterparts (Fig. 4b) . Upregulation of expression of the activation markers CD44, ICOS, PD-1 and CD40L was slightly lower in CD4tKO OT-II CD4 + T cells than in wild-type cells on days 2.5 and 3.5 but reached the wild-type expression by day 6.5 (Fig. 4c) . Consistent with a published report 29 , Bcl-6 expression was upregulated in almost all wild-type OT-II CD4 + T cells on day 2.5, with a fraction of these cells expressing CXCR5 (Fig. 4a,c) . Subsequently (days 3.5 and 6.5), Bcl-6 expression was downregulated in most wild-type OT-II CD4 + T cells, with about 30% of these cells remaining positive for both Bcl-6 and CXCR5; these presumably differentiated into T FH cells (Fig. 4a,c) . Notably, the upregulation of Bcl-6 expression was considerably impaired in CD4tKO OT-II CD4 + T cells throughout the entire period of observation, with a much smaller fraction of those cells than wild-type cells becoming Bcl-6 + CXCR5 hi T FH cells (Fig. 4a,c) . On day 6.5, the expression of Bcl-6 and CXCR5 in CD4tKO OT-II CD4 + cells remained lower than that in wild-type OT-II CD4 + cells (Fig. 4c) . We also examined the location of CD4tKO OT-II CD4 + cells in draining lymph nodes during immune responses. On day 2.5 after immunization, both wild-type and CD4tKO OT-II CD4 + cells had proliferated and resided in the T cell zone (Fig. 4b,d) . There was almost a complete lack of CD4tKO OT-II CD4 + T cells in B cell follicles and GCs on days 3.5 and 6.5, when wild-type OT-II CD4 + T cells had migrated into those areas en masse (Fig. 4d) . These results indicated that CD4tKO OT-II CD4 + T cells lost the ability to migrate to B cell follicles and GCs.
The miR-17~92 family regulates T FH cell generation after activation
The delayed upregulation of the expression of activation markers (CD44, ICOS, PD-1 and CD40L) and the compromised induction of expression of Bcl-6 and CXCR5 on day 2.5 of the immune response (Fig. 4a,c) showed that CD4tKO OT-II CD4 + T cells had early activation defects that may have indirectly compromised their T FH differentiation. To investigate that possibility, we generated 'OX40-Cre + miR-17~92 fl/fl miR-106a~363 −/− miR-106b~25 −/− ' mice, in which Cre recombinase driven by the promoter of the gene encoding OX40 is induced after activation of T cells and deletes the gene encoding miR-17~92 specifically in activated CD4 + T cells (called 'OX40tKO' hereafter). RNA blot analysis of CD4 + T cells activated in vitro with anti-CD3 and anti-CD28 showed that depletion of miR-17~92 started on day 2 and was completed on days 3-5 (Fig. 5a) . OX40tKO cells had a T FH -differentiation defect after immunization with NP-OVA in alum plus LPS (Fig. 5b,c) ; this defect was milder than that of CD4tKO cells, which probably reflected the modest role of the miR-17~92 family during the early phase of T cell activation. These results demonstrated an essential role for the a b npg A r t i c l e s was diminished only slightly ( Fig. 5d,e ). Together our results showed that the miR-17~92 family specifically regulated T FH differentiation beyond the initial phase of T cell activation. As follicular localization after activation is a critical step of the T FH -differentiation program, and deficiency in the miR-17~92 family substantially impaired that process (Fig. 4d) , this family may control T FH differentiation by specifically regulating molecular events that underlie the migration process.
Phosphatase PTEN partially contributes to miR-17~92 function
The inducible costimulator ICOS directly controls the migration of CD4 + T cells from the T cell-B cell border into B cell follicles in peripheral lymphoid organs 30 . The phosphatidylinositol-3-OH kinase (PI(3)K) pathway is the only known signaling pathway downstream of ICOS that is required for the development of T FH cells and GCs 31, 32 . Given the fact that PTEN (encoded by Pten, a direct target of the miR-17~92 family 24 ) antagonizes PI(3)K function, we first assessed whether the miR-17~92 family was able to promote the migration of CD4 + T cells into B cell follicles by augmenting ICOS-PI(3)K signaling via suppression of Pten. Indeed, naive CD4tKO CD4 + T cells had a greater abundance of PTEN than wild-type cells had, and PI(3)K downstream signaling was substantially impaired after stimulation with anti-CD3 plus anti-CD28 in vitro (Fig. 6a,b) . To determine the contribution of the greater abundance of PTEN to the T FH cell defect in CD4tKO mice, we generated CD4tKO mice with one loxP-flanked Pten allele (CD4tKOPten fl/+ mice). However, restoration of PTEN by the deletion of one copy of Pten in CD4tKO CD4 + T cells only partially (~25%) 'rescued' the T FH -differentiation defect in CD4tKO mice ( Fig. 6c-e ). In addition, restoration of the antibody response was marginal (Fig. 6f) . We also generated and analyzed CD4-Cre + Pten fl/+ mice to assess the contribution of PTEN to the phenotype of 17~92 tg/tg mice. Whereas young CD4-Cre + Pten fl/+ mice did not show any substantial alteration in the number or frequency of effector-memory T cells (data not shown), 9-month-old CD4-Cre + Pten fl/+ mice had more CD4 + T cells and CD44 + effector-memory T cells than did their wild-type counterparts (Supplementary Fig. 6a,b) , accompanied by spontaneous development of T FH cells and GC B cells reminiscent of that of young 17~92 tg/tg mice (Supplementary Fig. 6c,d) . 
npg
A r t i c l e s These results suggested that PTEN was indeed an important contributor to the regulation of T FH differentiation mediated by the miR-17~92 family but that additional, and possibly more important, molecules encoded by targets of the miR-17~92 family must also be involved in this process.
PHLPP2 mediates miR-17~92 control of T FH differentiation
It is thought that miRNAs target multiple components of functionally related pathways to achieve a substantial effect on the biological processes they regulate 5 . We examined additional components of the PI(3)K signaling pathway to identify potential targets of the miR-17~92 family. The phosphatase PHLPP2 inactivates the PI(3)K downstream effector Akt and is encoded by a target of the miR-17~92 family in human mantle cell lymphoma cell lines 33 . Mouse Phlpp2 has one miR-17-binding site and two miR-92-binding sites in its 3′ untranslated region, and those sites were responsive to miR-17~92mediated suppression in reporter assays (Fig. 7a,b) . The abundance of PHLPP2 was low in naive CD4 + T cells, increased considerably after T cell activation, peaked around day 2 and was diminished afterward ( Fig. 7c) . Consistent with a role for Phlpp2 as a target of the miR-17~92 family, CD4tKO CD4 + T cells had a greater abundance of activation-induced PHLPP2 than did wild-type cells (Fig. 7c) .
We hypothesized that such enhanced abundance beyond day 2 impaired ICOS-PI(3)K signaling and compromised the migration of T cells into B cell follicles. Indeed, adoptively transferred CD4tKO OT-II CD4 + T cells had much less activity of the PI(3)K pathway, as measured by phosphorylated ribosomal protein S6, on day 3.5 after immunization (Fig. 7d) , around the time that T cells began to migrate into B cell follicles. ICOS-PI(3)K signaling in vitro was compromised in activated CD4tKO CD4 + T cells, and this was not due to lower ICOS expression ( Fig. 7e and Supplementary Fig. 7a,b) . As PHLPP2-deficient mice have not been reported, we used retrovirusencoded short hairpin RNA (shRNA) to knock down the expression of Phlpp2 in CD4tKO CD4 + T cells to that in wild-type CD4 + T cells. This restored ICOS-PI(3)K signaling in previously activated CD4tKO CD4 + T cells ( Supplementary Fig. 7c,d) . We then infected CD4tKO OT-II CD4 + T cells with control retrovirus or retrovirus encoding Phlpp2-specific shRNA and adoptively transferred those cells into wild-type recipients, then analyzed their differentiation into T FH cells after immunization of the recipient mice with OVA in alum. Knockdown of PHLPP2 in CD4tKO OT-II CD4 + T cells substantially restored their ability to differentiate into T FH cells in vivo and partially restored their migration into B cell follicles ( Fig. 7f,g) . Conversely, overexpression of PHLPP2 in wild-type CD4 + T cells impaired their ICOS-PI(3)K signaling and their ability to migrate into B cell follicles but did not alter their differentiation into Bcl-6 + CXCR5 hi cells ( Fig. 7h and Supplementary Fig. 8) . These results were consistent with the finding that ICOS signaling controls follicular recruitment of CD4 + T cells independently of CXCR5 and Bcl-6 expression 30 . Together, our data demonstrated that PHLPP2 was an important regulator of the migration of CD4 + T cells into B cell follicles and that miR-17~92 family controlled T FH differentiation in part by limiting the T cell activation-induced abundance of PHLPP2 to the proper range that allowed productive ICOS-PI(3)K signaling to drive the migration of T cells into B cell follicles (Supplementary Fig. 9 ).
DISCUSSION
Given our results here, we propose the following model of regulation of T FH differentiation mediated by the miR-17~92 family. Expression of both the miR-17~92 family and its target gene Phlpp2 is low in naive CD4 + T cells. Expression of these is induced after T cell activation, peaks around day 2 and is downregulated afterward. Downregulation of Phlpp2 expression after day 2 is critical for signaling via ICOS-PI(3)K, which drives the migration of T cells into B cell follicles 30 , a defining feature of the T FH -differentiation program. Expression of PHLPP2 is induced by activation of CD4 + T cells mediated by the T cell antigen receptor, and upregulation of the miR-17~92 family serves to limit that activation-induced PHLPP2 expression to an appropriate range, as exaggerated and prolonged expression of PHLPP2 would impair ICOS-PI(3)K signaling. Indeed, complete deletion of the miR-17~92 family in T cells resulted in dysregulated PHLPP2 expression, compromised ICOS-PI(3)K signaling, blocked migration into B cell follicles and impaired T FH differentiation. As the migration of T cells into B cell follicles is not required for the differentiation of other CD4 + effector T cell subsets, this model explains why T FH differentiation was so compromised in OX40tKO mice during infection with LCMV, Armstrong strain, whereas T H 1 differentiation remained relatively normal in those mice. The complete blockade of the migration of CD4tKO CD4 + T cells into B cell follicles was almost identical to that caused by ICOS deficiency 30 . However, CD4tKO CD4 + T cells were still able to differentiate into Bcl-6 + CXCR5 hi cells, although at a much lower efficiency than that of their wild-type counterparts. That is in contrast to ICOSdeficient CD4 + T cells, whose differentiation into Bcl-6 + CXCR5 hi cells is completely abolished 34 . The differences in the regulation of follicular recruitment and differentiation into Bcl-6 + CXCR5 hi cells by the miR-17~92 family and ICOS suggest that these two facets of the T FH -differentiation program are controlled by distinct yet partially overlapping molecular pathways. That idea is further supported by the consequences of PHLPP2 overexpression in wild-type CD4 + T cells, which substantially impaired their recruitment to follicles but not their differentiation into Bcl-6 + CXCR5 hi cells. Elucidation of molecular pathways underlying these two facets holds the key to understanding the T FH -differentiation program.
We note that Phlpp2 is not the only functionally important target through which the miR-17~92 family regulates T FH differentiation, as knockdown of PHLPP2 only partially restored the recruitment of CD4tKO OT-II CD4 + T cells to follicles and the T FH differentiation of those cells. PTEN is another important mediator of miR-17~92 function, as deletion of one copy of the Pten partially restored the differentiation of T FH cells and GC B cells in CD4tKO mice. Other functionally important targets may exist and mediate the control of various aspects of the T FH -differentiation program by the miR-17~92 family. Future investigation is needed to identify additional targets and evaluate their contribution to the functions of the miR-17~92 family.
Published studies have shown that the miR-17~92 family regulates the activation and proliferation of CD4 + T cells in vitro 24, 35 . By examining CD4tKO OT-II CD4 + T cells during immune responses to a protein antigen, we showed that deficiency in the miR-17~92 family had a negligible effect on the proliferation of CD4 + T cells and resulted in a modest delay in their activation in vivo. That delayed activation was not the direct cause of the T FH -differentiation defect in CD4tKO mice, as deletion of the miR-17~92 family by OX40-Cre beyond the initial activation phase resulted in a similar T FH -differentiation defect. Therefore, the miR-17~92 family has a general role in the activation of CD4 + T cells and a specific role in their differentiation into T FH cells. In summary, our loss-and gain-of function studies have have identified the miR-17~92 family as a critical regulator of T FH differentiation and the Akt phosphatase PHLPP2 as an important mediator of the functions of the miR-17~92 family. Given the crucial roles of T FH cells in GC reaction and antibody responses, manipulating miR-17~92 family of miRNAs or their target genes and pathways in vivo npg may facilitate the design of better vaccines and the development of therapeutic regimens for treating autoimmune diseases.
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Methods and any associated references are available in the online version of the paper.
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